Edition:
India

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

596.05INR
3:59pm IST
Change (% chg)

Rs13.20 (+2.26%)
Prev Close
Rs582.85
Open
Rs585.95
Day's High
Rs615.75
Day's Low
Rs580.55
Volume
2,310,393
Avg. Vol
501,905
52-wk High
Rs695.00
52-wk Low
Rs233.15

Select another date:

Thu, Jun 18 2020

BRIEF-Shilpa Medicare March Quarter Consol Profit Rises

* MARCH QUARTER CONSOL NET PROFIT 345.7 MILLION RUPEES VERSUS 238.8 MILLION RUPEES

BRIEF-Shilpa Medicare- Approved To Acquire FTF Pharma Pvt Ltd

* APPROVED TO BUY AUXILLA PHARMACEUTICALS AND RESEARCH LLP VIA UNIT

BRIEF-India's Shilpa Medicare March-Qtr Consol Net Profit Rises

* MARCH-QUARTER CONSOL NET PROFIT 345.7 MILLION RUPEES VERSUS 238.8 MILLION RUPEES YEAR AGO

BRIEF-Shilpa Medicare Launches Indian Branded Generic Of Anti-Cancer Drug Ibrutinib

* LAUNCHES INDIAN BRANDED GENERIC OF ANTI-CANCER DRUG IBRUTINIB, WITH BRAND NAME IBRUSHIL

BRIEF-Shilpa Medicare -Approved Establishing Units In Canada And Spain

* SHILPA MEDICARE LTD -APPROVED ESTABLISHING UNITS IN CANADA AND SPAIN Source text for Eikon: Further company coverage:

BRIEF-Shilpa Medicare Gets UK MHRA Approval For Imatinib Oral Solution

* THROUGH UK UNIT KOANAA HEALTHCARE, GETS UK MHRA APPROVAL FOR IMATINIB ORAL SOLUTION

Select another date: